Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biotechnology, offering transformative therapeutic solutions […]
Understanding the MAH Japan System In Japan, the Marketing Authorization Holder (MAH) is central in the […]
The recent regulatory changes in Japan’s pharmaceutical sector present a significant opportunity for non-Japanese companies. By […]
Expanding your pharmaceutical operations into Japan is a strategic move with an immense growth potential. However, […]
Embracing Opportunities in Japan With great excitement and a sense of humble pride, I share our […]
Japan is a beacon of innovation globally, especially in the pharmaceutical sector. Notably, the rise of […]